Synergistic Lopinavir /Ritonavir (Lopikast) Combination Manufactured by Aprazer Healthcare
The advanced Anti-retroviral drugs have dramatically led to the decline of HIV infection.
The mortality rate has fallen by about 70 percent.
The drugs reduce the viral count to undetectable levels, significantly reducing the risk of transmission.
The anti –retroviral drugs make the disease manageable and increase survival rates/years.
The commonly used Lopinavir /Ritonavir combination – Lopikast
Lopinavir /Ritonavir (Lopikast) is widely used for HIV treatment.
It is a globally available HIV medicine.
It is a combination of strong antivirals with a booster molecule.
Ritonavir increases the efficacy of Lopinavir many fold.
The key benefits include-
- It suppresses HIV virus to undetectable levels.
- It delays HIV progression to AIDs.
- It has a high barrier to resistance.
Aprazer Healthcare – Advancing HIV treatment
Aprazer Healthcare specializes in manufacturing HIV drugs.
Manufacturing a large range of antiretroviral combination drugs, we are a top tier generic HIV medicine manufacturer.
With an aim to eradicate HIV, we manufacture affordable HIV generic combinations.
Aprazer Healthcare is at the forefront in saving lives in HIV epidemic areas.
Aprazer Healthcare is a reliable drug exporter, supplying affordable HIV medicine to countries in Africa, Asia and America.
Why is Lopinavir combined with Ritonavir?
Lopinavir is a strong antiviral medicine.
Ritonavir is added to enhance the effect of Lopinavir.
Lopinavir breaks down at a faster rate in the body.
Ritonavir inhibits the breakdown.
It prolongs lopinavir activity.
Is it safe to be used in pediatric patients?
It is not recommended to be used in neonates before 14 days of age.
Children may require twice drug dosing than adults due to faster elimination of the drug.
Lopinavir /Ritonavir (Lopikast) is given in pregnancy. Is it safe?
It is commonly used to prevent HIV transmission from mother to the child.
It reduces the risk of preterm delivery.
It does not harm the fetus.
Can Lopikast stop viral transmission?
It drops the viral count to negligible.
It prevents transmission of virus from one person to another.
Lopinavir /Ritonavir (Lopikast) combination long-term side effects-
- Hyperlipidemia
- Insulin resistance
- Fat accumulation around abdomen
- Fat wasting around arms, legs
- Increased risk of kidney stones
- Bone loss
- Pancreatitis risk
Lopikast (Lopinavir/Ritonavir) combination – The two drugs engineered to form a single pill offers high resistance barrier and uncompromised suppression.
